Thursday, June 1, 2017

ASCO Preview: Cost of BR vs RCHOP in Follicular Lymphoma

›
Another ASCO preview. This one is for a session called " Differences in Health Care Costs and Utilization: BR vs RCHOP in Patients with...
1 comment:
Saturday, May 27, 2017

CAR-T for Transformed FL Gets Priority Review from FDA

›
The FDA has granted a faster-than-usual review for yet another Follicular Lymphoma treatment. This one is for KTE-C19, a type of CAR-T thera...
1 comment:
Tuesday, May 23, 2017

ASCO: Lenalidomide plus Obinutuzumab in Relapsed FL

›
Another ASCO preview. This time, a look at the results from phase I and phase II trials for Lenalidomide plus Obinutuzumab. This seems l...
Friday, May 19, 2017

ASCO: Copanlisib for Follicular Lymphoma

›
It's that time of year! ASCO abstracts are out! In early June every year, the American Society of Clinical Oncology (ASCO) holds its a...
4 comments:
Monday, May 15, 2017

Impact of Treatment in Long-Term Survival of FL

›
The journal PLOS ONE just published an article called " Impact of Treatment in Long-Term Survival Patients with Follicular Lymphoma: A...
2 comments:
Wednesday, May 10, 2017

Does Chemo Still Have a Role in FL?

›
Healio posted a short debate a few days ago, asking the question: Does chemotherapy still have a role in follicular lymphoma treatment? Th...
Saturday, May 6, 2017

Maintenance Rituxan Improves Overall Survival in FL?

›
New research published in the European Journal of Cancer suggests that Rituxan Maintenance after chemotherapy might improve Overall Surviva...